Amino Acids

Threonine - Therapy for Mental Illness

Threonine - Therapy for mental Illness

Threonine is an essential amino acid. Along with lysine, it is deficient in most foodgrains, but present in most pulses. A combination of foodgrains and pulses provides an adequate supply of these amino acids in a vegetarian diet.

Threonine is necessary for. the development and proper functioning of the brain, particularly in children. It also has a powerful anti-convulsive effect.

Recommended Daily Allowance - Threonine
Men 8 mg
Women 8 mg
Children 28 mg
Infants 63 mg

Threonine Benefits - Functions in the Body

Threonine Benefits

Cheraksin Williams lists threonine, along with most of the B vitamins, magnesium, ascorbic acid, iodine, potassium, tryptophan, lysine, inositol, and glutamic acid as being essential in the prevention and treatment of mental illness.

Threonine is said to be very useful in indigestion' and intestinal malfunctions, as well as prevention of excessive fat in the liver. A fatty liver, resulting from a low-protein diet, can be corrected by threonine.

Threonine Food Sources

Threonine Food Sources

Threonine is found in poultry, pork, and leafy vegetables. Whole grains, pulses, nuts, apples, peaches, and figs also contain threonine.

Threonine Deficiency Symptoms

Deficiency of threonine can result in irritability in children.

Leave your comments

Health News

Surgeon Removes Eight Pound Liver Tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable. Then he was referred to Dr... [ read article ]

NIPPV Linked To Increased Hospital Mortality Rates In Small Group Of Patients

Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of... [ read article ]

FDA Approves Label Update For PREZISTA® To Include 192-Week Data In HIV-1-Infected Adult Patients

Starting Treatment Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study... [ read article ]

Recommended Stuff

Our Latest Blog Entries...